.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Colorcon
McKesson
Citi
Teva
Mallinckrodt
Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
Cerilliant

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090812

« Back to Dashboard

NDA 090812 describes POLYETHYLENE GLYCOL 3350, which is a drug marketed by Ailex Pharms Llc, Ani Pharms Inc, Breckenridge Pharm, Mylan, Nexgen Pharma, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharm Inc, Paddock Llc, Par Pharm, Perrigo R And D, Strides Pharma, and Teva Pharms, and is included in fifteen NDAs. It is available from sixty-eight suppliers. Additional details are available on the POLYETHYLENE GLYCOL 3350 profile page.

The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

Summary for 090812

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 090812

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 090812 ANDA Nexgen Pharma, Inc. 0722-7116 0722-7116-02 14 d in 1 BOTTLE (0722-7116-02)
POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 090812 ANDA Nexgen Pharma, Inc. 0722-7116 0722-7116-01 7 d in 1 BOTTLE (0722-7116-01)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:FOR SOLUTION;ORALStrength17GM/SCOOPFUL
Approval Date:Oct 7, 2009TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Chinese Patent Office
Farmers Insurance
Fuji
Harvard Business School
Dow
UBS
Teva
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot